Troy Edward Wilson, Director at Avidity Biosciences, Inc. (RNA), sold 29,500 shares at $50.00 ($1.5M) on 2025-09-05, disclosed to the SEC on 2025-09-09.
Scheduled sale ($1.5M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.00 | 14,500 | $725K | 49.2% |
| 2 | $50.00 | 15,000 | $750K | 50.8% |
| Total | $50.00 avg | 29,500 | $1.5M | 100% |
| Filing → |
| KURA | BUY | 2026-08-17 | $1.1M | — | Filing → |
| PBYI | SELL | 2026-06-15 | $78K | — | Filing → |
| KURA | SELL | 2025-09-29 | $655K | — | Filing → |